Treatment of acyclovir-resistant herpes simplex virus with continuous infusion of high-dose acyclovir in hematopoietic cell transplant patients.

Authors :: Kim JH
Schaenman JM
Ho DY
Brown JM
Source :: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2011 Feb; Vol. 17 (2), pp. 259-64. Date of Electronic Publication: 2010 Jul 06.
Publication Year :: 2011
Abstract: Infection because of herpes simplex virus (HSV) that is resistant to acyclovir (ACV) poses treatment challenges in hematopoietic cell transplant (HCT) patients. We present a series of patients with ACV-resistant HSV following HCT who were successfully treated with continuous infusion high-dose ACV after failing standard treatment regimens for ACV-resistant HSV.<br /> (Copyright © 2011 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.)

Language :: English
ISSN :: 1523-6536
Volume :: 17
Issue :: 2
Database :: MEDLINE
Journal :: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Publication Type :: Academic Journal
Accession number :: 20615475
Full Text :: https://doi.org/10.1016/j.bbmt.2010.06.020

Full Text Access

Tools